Penn Medicine Provider
Hematology, Medical Oncology
Stephen E. Zrada, MD
4.9
(1384)
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Sewell
View 2 additional locations
Make an appointmentCall 800-789-7366

About me

In addition to Penn Medicine hospital privileges, Dr. Zrada also has privileges at Virtua Voorhees Hospital, a Penn Medicine Strategic Alliance partner.

Education and training

  • Medical School: Drexel University Center City Hahnemann Campus
  • Residency: Hahnemann University Hospital
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.9

1384 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
everyone is very helpful
May 2025
5.0
5.0
he's a good dr
May 2025
5.0
5.0
the doctor was very nice
May 2025
5.0
5.0
outstanding

Insurance accepted

My Locations

Learn about location
Learn about location
Learn about location

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Zrada is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

My research

Yardley DA1, 2, Kaufman PA3, Huang W4, Krekow L5, Savin M6, Lawler WE7, Zrada S8, Starr A9, Einhorn H10, Schwartzberg LS11, Adams JW12, Lie Y13, Paquet AC14, 15, Sperinde J16, Haddad M17, 18, Anderson S19, Brigino M20, Pesano R21, 22, Bates MP23, 24, Weidler J25, 26, Bosserman L27, 28. Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival. , Breast Cancer Res, 18: 2015,17-41

Treat J1, Damjanov N, Huang C, Zrada S, Rahman A. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. , Oncology (Williston Park)., 15: 2001,44-8

DeMoraes E, Fogler W, Zrada SE Recombinant HumanAngiostatis (RHA): A Phase I Clinical Trial Assessing Safety, Pharmacokinetics (PK) and Pharmacodynamics , American Society of Clinical Oncology.: 2001

Zrada SE, Mastrangelo M Complete Remission of Metastatic Melanoma after Treatment with the “Dartmouth” Chemotherapy Regimen , American Society of Clinical Oncology.: 2001

Treat JA, Zrada, S A Phase I Trial in Advanced Malignancies with Liposomal Encapsulated Paclitaxel (LEP). , American Society of Clinical Oncology.: 1999

Zrada SE, Findelstein JM. Anomalous articulation of the first rib mimicking supraclavicular neoplasia. , Otolaryngology-Head and Neck Surgery. , 116(3): 1997,389-391

Zrada SE1, Finkelstein JM. Anomalous articulation of the first rib mimicking supraclavicular neoplasia. , Otolaryngol Head Neck Surg., 116(3): 1997,389-91

Doty RL, Zrada SE. Smell and Taste Disorders , Principles and Practice of Geriatric Medicine. : 1997

Zrada SE, Doty RL. Olfactory dysfunction in Usher syndrome. , American Journal of Medical Genetics. , 64(4): 1996,602-603

Zrada SE, Isaacson G. Endoscopic management of pediatric ethmoid mucoceles. , American Journal of Otolaryngology. , 17(3): 1996,197-201